Yale-BioHaven Entrepreneurship Seminar: 454 Life Sciences aiming for the $10K Human Genome

New Haven, Conn. -- The Yale BioHaven Entrepreneurship Seminar series focuses on 454 Life Sciences on Wednesday, November 8 from 3:30 to 5 p.m. in the Anlyan Center Auditorium of Yale Medical School, 300 Cedar Street.

The speaker will be Christopher McLeod, President and CEO of 454 Life Sciences, established in 2000 as a technology development subsidiary of the Branford, Conn.-based biotechnology company CuraGen Corporation. 454 Life Sciences develops and commercializes novel instrumentation and technology for conducting high-throughput nucleotide sequencing, with specific application to whole-genome sequencing and ultra-deep sequencing of target genes.

The hallmarks of 454 SequencingTM are that it has simple, unbiased sample preparation and high capacity for parallel sequencing. This technology has dramatically increased the feasibility and lowered the cost of large-scale sequencing projects such as the initiative to analyze an individual human genome for $10,000.

The 454 Life Sciences instrumentation, the Genome Sequencer 20TM System, allows one individual to prepare and sequence an entire genome after performing a single sample preparation -- no matter the size of the genome studied. A single instrument using patented light emitting sequencing chemistries produces sequence information at more than 60-times the capacity of instruments using the current technology.

In 2005, the company entered into an agreement with Roche for the promotion, sale, and distribution of 454 Life Sciences' sequencing systems, including proprietary kits and reagents. 454 SequencingTM is being used today by the Max Planck Institute to reconstruct the genome of the Neandertal man, the Dana-Farber Cancer Institute and Broad Institute to detect cancer gene mutations, and the International Census of Marine Microbes to study microbial life in the world's oceans and its impact on our ecosystems.

Refreshments and

Contact: Janet Rettig Emanuel
Yale University

Page: 1 2

Related biology news :

1. Developer of new method for treating bone defects wins WPI Entrepreneurship Award
2. Yale BioHaven Entrepreneurship Seminars begin with TheraLogics
3. Device that aids people with muscular dystrophy wins inaugural WPI Entrepreneurship Award
4. Yale BioHaven Entrepreneurship Seminar series launched
5. Institute for OneWorld Health awarded Skoll Foundations Social Entrepreneurship Award
6. UT and Atom Sciences Collaborate on NIH grant to develop test for major african disease
7. 454 Life Sciences and Baylor College of Medicine complete sequencing of DNA pioneer
8. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies
9. University of Arizona neurobiologist John Hildebrand elected to the National Academy of Sciences
10. Dr. Michael Petrides: Elected to the American Academy of Arts and Sciences
11. Einsteins Dr. Vern Schramm elected to the National Academy of Sciences

Post Your Comments:

(Date:7/2/2020)... , ... July 01, 2020 , ... ... its phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory ... 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/25/2020)... , ... June 24, 2020 , ... ... enterprise software and software-driven clinical data services that accelerate drug development, is collaborating ... selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... With ... a vaccine or drug treatment. In an effort to better understand the cellular ... the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 approved ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, ... announced today that Derek Fournier has been appointed CEO and President. Founder and ... effective immediately. , “DeCurtis Corporation has been on an incredible journey for ...
(Date:6/19/2020)... ... June 18, 2020 , ... The Vitaspace project was founded ... forces to radically prolong life and find a way (medicine or technology) that will ... was supported by various scientists from all over the world, doctors, and all people ...
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has ... From the Paris Agreement to stock market dips, ways to reduce CO2 is something ... to their portfolio. Most of the biofuels being produced today are created from recycled ...
Breaking Biology Technology:
Cached News: